查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球生物相容性涂料市场按类型(抗菌,亲水),材料(聚合物,陶瓷,金属),最终用途行业(医疗,食品和饮料,医疗器械),地区(亚太,欧洲,北美,中东和非洲,南美)预测到2028
市场调查报告书
商品编码
1306573

全球生物相容性涂料市场按类型(抗菌,亲水),材料(聚合物,陶瓷,金属),最终用途行业(医疗,食品和饮料,医疗器械),地区(亚太,欧洲,北美,中东和非洲,南美)预测到2028

Biocompatible Coatings Market by Type (Antibacterial, hydrophilic), Material (Polymer, Ceramics, Metal), End-Use Industry (Healthcare, Food & Beverage, Medical Devices), & Region (APAC, Europe, North America, MEA & SA) - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 210 Pages | 订单完成后即时交付

价格
简介目录

全球生物相容性涂料市场规模预计将从2022年的146亿美元增长到2028年的297亿美元，复合年增长率为12.4%。

按材料类型划分，聚合物预计将在 2022 年占据最大的市场份额。

“医疗设备应用将在预测期内实现最高复合年增长率”

从最终用途行业来看，医疗器械领域预计在预测期内復合年增长率最高。 该领域包括各种需要生物相容性涂层以增强性能,功能和生物相容性的医疗设备和植入物。 慢性病的增加,人口老龄化和医疗技术的进步正在推动对医疗设备和植入物的需求。 生物相容性涂层在提高这些设备的生物相容性,降低副作用风险和提高整体性能方面发挥着重要作用。 生物相容性涂层广泛用于各种医疗器械，包括骨科植入物,心血管支架,牙科植入物,手术器械,导管和假肢。 这些涂层具有减少摩擦,提高耐磨性,增强生物相容性和控製药物释放等优点。 延长医疗设备的使用寿命和性能，从而改善患者的治疗效果。

“北美生物相容性涂料市场将在 2022 年占据最大份额”

北美的特点是强大的医疗行业,先进的医疗技术和严格的监管标准，这推动了对生物相容性涂料的需求。 该地区拥有大量医疗器械製造商和机构，刺激了生物相容性涂层在各种医疗应用中的采用。 慢性疾病的增加,人口的迅速老龄化以及对先进医疗解决方案日益增长的兴趣，增加了对需要生物相容性涂层以增强生物相容性和性能的医疗设备和植入物的需求。 该地区正在生物相容性涂料领域进行重大研究和开发。 学术机构,研究机构和行业参与者之间的合作正在推动先进涂层技术的创新和发展。 表面改性技术,涂层材料和功能化方法的不断进步进一步推动了北美生物相容性涂层市场的增长。

“美国生物相容性涂料市场将在 2022 年占据最大份额”

美国拥有高度发达的医疗基础设施和大量的患者。 该国以其在医疗设备,植入物和医疗解决方案方面的技术进步和创新而闻名。 因此，对生物相容性涂层的需求显着增长，以提高各种医疗保健环境中使用的医疗器械的性能,生物相容性和安全性。

美国是主要医疗器械製造商和研究机构的所在地，为生物相容性涂料市场的增长做出了贡献。 美国拥有许多领先的公司和研究中心，专注于创新医疗设备和植入物的开发和商业化。 这些公司依靠生物相容性涂料来提高其产品的性能和生物相容性，从而推动了美国市场对此类涂料的需求。

内容

第一章简介

第 2 章研究方法

第 3 章执行摘要

第 4 章重要考虑因素

第五章市场概述

  • 简介
  • 市场动态
    • 驱动程序
    • 制约因素
    • 机会
    • 任务
  • 波特五力分析
  • 主要利益相关者和采购标准
  • 宏观经济指标
  • 全球医疗行业趋势与预测
  • 技术分析
  • 案例研究分析
  • 价格分析
  • 贸易数据统计
  • 世界经济形势：对市场增长的影响
  • 价值链分析
  • 生态系统分析和互连市场
  • 影响买家/客户的趋势/干扰
  • 专利分析
  • 关税和法规
  • 监管状况和标准
  • 重大会议和活动(2023 年)

第 6 章生物相容性涂料市场：按材料类型

  • 简介
  • 聚合物
  • 陶瓷
  • 金属
  • 其他

第 7 章生物相容性涂料市场：按涂料类型

  • 简介
  • 抗菌涂层
  • 亲水涂层
  • 其他

第 8 章生物相容性涂料市场：按最终用途行业划分

  • 简介
  • 医疗
  • 食品和饮料
  • 医疗设备
  • 其他

第 9 章生物相容性涂料市场：按地区

  • 简介
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 亚太地区其他地区
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 意大利
    • 欧洲其他地区
  • 中东和非洲
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 其他中东和非洲地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区

第 10 章竞争格局

  • 概述
  • 企业评估矩阵(2022 年)
  • 初创企业/中小企业评估矩阵(2022 年)
  • 竞争基准测试
  • 市场份额分析
  • 市场排名分析
  • 利润分析
  • 竞争场景
  • 战略制定状况

第 11 章公司简介

  • 主要公司
    • SURMODICS, INC.
    • DSM BIOMEDICAL
    • HYDROMER, INC.
    • AST PRODUCTS, INC.
    • BIOCOAT INCORPORATED
    • BIOINTERACTIONS LIMITED
    • FREUDENBERG MEDICAL
    • COVALON TECHNOLOGIES LTD.
    • ACULON, INC
    • APPLIED MEDICAL COATINGS
  • 其他主要企业
    • ADVANSOURCE BIOMATERIALS CORPORATION
    • SURFACE SOLUTIONS GROUP, LLC
    • LINCOTEK MEDICAL
    • POLY-MED, INC.
    • PRECISION COATING COMPANY, INC.
    • SPECIALTY COATING SYSTEMS, INC.
    • HEMOTEQ AG
    • HARLAND MEDICAL SYSTEMS
    • ISURTEC
    • WHITFORD CORPORATION
    • MILLER-STEPHENSON
    • ENDURA COATINGS
    • APPLIED MEMBRANE TECHNOLOGY
    • COATINGS2GO
    • FORMACOAT, LLC

第 12 章邻近及相关市场

  • 简介
  • 亲水涂料市场：定义
  • 亲水涂料市场：概述

第13章附录

简介目录
Product Code: CH 8692

The biocompatible coatings market size is projected to reach USD 29.7 billion by 2028 at a CAGR of 12.4% from USD 14.6 billion in 2022. The polymer, by material type segment is estimated to account for the largest share of the biocompatible coatings market in 2022.

Medical Devices application is estimated to register the highest CAGR during the forecast period

The medical device segment of the biocompatible coatings market is projected to register the highest CAGR during the forecast period. This segment encompasses a wide range of medical devices and implants that require biocompatible coatings to enhance their performance, functionality, and biocompatibility. The increasing prevalence of chronic diseases, the aging population, and advancements in medical technology drive the demand for medical devices and implants. Biocompatible coatings play a critical role in improving the biocompatibility of these devices, reducing the risk of adverse reactions, and enhancing their overall performance. Biocompatible coatings are used in various medical devices, including orthopedic implants, cardiovascular stents, dental implants, surgical instruments, catheters, and prosthetics. These coatings provide benefits such as reduced friction, improved wear resistance, enhanced biocompatibility, and controlled drug release, among others. They help improve the longevity and performance of medical devices, leading to better patient outcomes.

North America biocompatible coatings market is expected to account for largest share in 2022

North America is characterized by a robust healthcare industry, advanced medical technology, and stringent regulatory standards, which drive the demand for biocompatible coatings. The region is home to a large number of medical device manufacturers and healthcare institutions, fueling the adoption of biocompatible coatings in various medical applications. The increasing prevalence of chronic diseases, a rapidly aging population, and a focus on advanced healthcare solutions contribute to the demand for medical devices and implants, which require biocompatible coatings to enhance their biocompatibility and performance. The region witnesses significant research and development activities in the field of biocompatible coatings. Collaboration between academic institutions, research organizations, and industry players fosters innovation and the development of advanced coating technologies. Ongoing advancements in surface modification techniques, coating materials, and functionalization approaches further propel the growth of the biocompatible coatings market in North America.

US biocompatible coatings market is projected to account for largest share in 2022

The United States has a highly developed healthcare sector with advanced medical infrastructure and a large patient population. The country is known for its technological advancements and innovation in medical devices, implants, and healthcare solutions. As a result, there is a significant demand for biocompatible coatings to enhance the performance, biocompatibility, and safety of medical devices used in various healthcare settings.

the presence of major medical device manufacturers and research institutions in the United States contributes to the growth of the biocompatible coatings market. The country is home to many leading companies and research centers that focus on the development and commercialization of innovative medical devices and implants. These companies rely on biocompatible coatings to enhance the performance and biocompatibility of their products, driving the demand for such coatings in the US market.

The break-up of the profile of primary participants in the texture paint market:

  • By Company Type: Tier 1 - 39%, Tier 2 - 34%, and Tier 3 - 27%
  • By Designation: C Level - 30%, D Level - 30%, and Others - 40%
  • By Region: Asia Pacific- 40%, North America - 20%, Europe - 20%, Middle East & Africa - 10%, and South America - 10%

Prominent companies includes SurModics, Inc. (US), DSM Biomedical (US), Hydromer Inc. (US), Covalon Technologies Ltd. (Canada), Hemoteq AG (Germany) and others.

Research Coverage:

This research report provide detailed segmentation of biocompatible coatings market by type (Antibacterial, Hydrophilic, and Others), by material (Polymers, Ceramics, Metal and Others), by end-use industry (Healthcare, Food & Beverage, Medical Devices, and Others) and region (North America, Europe, Asia Pacific, the Middle East & Africa, and South America). The report covers detailed information about the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the biocompatible coatings market. A thorough analysis of the major industry players has been conducted to provide insights into their business overview, products, finances; key strategies;. new product launches, mergers and acquisitions, and significant changes affecting the biocompatible coatings market. In order to better position their companies and develop effective go to market strategies, stakeholder will benefit from the competitive landscape and gaining additional insight from this report.

The report Provides insights on the following pointers:

  • Analysis of key drivers (Increasing demand for medical devices implants), restraints (High development and manufacturing cost), opportunity (Increasing healthcare expenditure) and challenges (stringent regulatory requirements).
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the texture paint market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the texture paint market across varied regions
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the biocompatible coatings market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like SurModics, Inc. (US), DSM Biomedical (US), Hydromer Inc. (US), Covalon Technologies Ltd. (Canada), Hemoteq AG (Germany) and others. The report also helps stakeholders understand the pulse of the biocompatible coatings market and provides them information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 REGIONAL SCOPE
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 UNIT CONSIDERED
  • 1.6 LIMITATIONS
  • 1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 BIOCOMPATIBLE COATINGS MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key primary data sources
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 TOP-DOWN APPROACH
    • FIGURE 2 BIOCOMPATIBLE COATINGS MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
    • FIGURE 3 BIOCOMPATIBLE COATINGS MARKET SIZE ESTIMATION, BY VALUE
    • FIGURE 4 BIOCOMPATIBLE COATINGS MARKET SIZE ESTIMATION, BY REGION
    • FIGURE 5 BIOCOMPATIBLE COATINGS MARKET SIZE ESTIMATION, BY MATERIAL TYPE
    • FIGURE 6 BIOCOMPATIBLE COATINGS MARKET SIZE ESTIMATION, BY END USE INDUSTRY
    • 2.2.2 BOTTOM-UP APPROACH
    • FIGURE 7 BIOCOMPATIBLE COATINGS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • 2.3 MARKET GROWTH FORECAST
    • 2.3.1 SUPPLY-SIDE ANALYSIS
    • FIGURE 8 METHODOLOGY FOR SUPPLY-SIDE SIZING OF BIOCOMPATIBLE COATINGS MARKET
    • FIGURE 9 BIOCOMPATIBLE COATINGS MARKET: SUPPLY-SIDE FORECAST
    • 2.3.2 DEMAND-SIDE ANALYSIS
    • FIGURE 10 BIOCOMPATIBLE COATINGS MARKET: DEMAND-SIDE FORECAST
  • 2.4 FACTOR ANALYSIS
    • FIGURE 11 BIOCOMPATIBLE COATINGS MARKET: FACTOR ANALYSIS
  • 2.5 DATA TRIANGULATION
    • FIGURE 12 BIOCOMPATIBLE COATINGS MARKET: DATA TRIANGULATION
  • 2.6 RESEARCH ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS
  • 2.8 RISK ANALYSIS
  • 2.9 GROWTH FORECAST
  • 2.10 IMPACT OF RECESSION

3 EXECUTIVE SUMMARY

    • TABLE 1 BIOCOMPATIBLE COATINGS MARKET SNAPSHOT, 2022 VS. 2028
    • FIGURE 13 ASIA PACIFIC BIOCOMPATIBLE COATINGS MARKET TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
    • FIGURE 14 MEDICAL DEVICE END USE INDUSTRY TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD IN BIOCOMPATIBLE COATINGS MARKET
    • FIGURE 15 POLYMER BIOCOMPATIBLE COATINGS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
    • FIGURE 16 NORTH AMERICA WAS LARGEST BIOCOMPATIBLE COATINGS MARKET IN 2022

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN BIOCOMPATIBLE COATINGS MARKET
    • FIGURE 17 EMERGING ECONOMIES TO OFFER OPPORTUNITIES TO BIOCOMPATIBLE COATING MANUFACTURERS
  • 4.2 BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE
    • FIGURE 18 POLYMER BIOCOMPATIBLE COATINGS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2028
  • 4.3 ASIA PACIFIC: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY AND COUNTRY
    • FIGURE 19 CHINA AND FOOD & BEVERAGE SEGMENTS ACCOUNTED FOR LARGEST MARKET SHARES
  • 4.4 BIOCOMPATIBLE COATINGS MARKET, DEVELOPED VS. EMERGING ECONOMIES
    • FIGURE 20 BIOCOMPATIBLE COATINGS MARKET TO REGISTER HIGHER CAGR IN EMERGING ECONOMIES
  • 4.5 BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY
    • FIGURE 21 INDIA TO REGISTER HIGHEST CAGR BETWEEN 2023 AND 2028

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 22 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN BIOCOMPATIBLE COATINGS MARKET
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for medical devices and implants
      • 5.2.1.2 Growing awareness of patient safety
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High development and manufacturing costs
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing focus on infection control
      • 5.2.3.2 Increasing healthcare expenditure
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Stringent regulatory requirements
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 2 BIOCOMPATIBLE COATINGS MARKET: IMPACT OF PORTER'S FIVE FORCES
    • FIGURE 23 PORTER'S FIVE FORCES ANALYSIS OF BIOCOMPATIBLE COATINGS MARKET
    • 5.3.1 THREAT OF NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF BUYERS
    • 5.3.4 BARGAINING POWER OF SUPPLIERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
    • TABLE 3 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 2 END USE INDUSTRIES (%)
    • 5.4.2 BUYING CRITERIA
    • FIGURE 25 KEY BUYING CRITERIA FOR BIOCOMPATIBLE COATINGS
    • TABLE 4 KEY BUYING CRITERIA FOR BIOCOMPATIBLE COATINGS
  • 5.5 MACROECONOMIC INDICATORS
    • 5.5.1 INTRODUCTION
    • 5.5.2 TRENDS AND FORECASTS OF GDP
    • TABLE 5 GDP PERCENTAGE CHANGE OF KEY COUNTRIES, 2020-2028
  • 5.6 TRENDS AND FORECASTS OF GLOBAL HEALTHCARE INDUSTRY
    • FIGURE 26 HEALTHCARE TECH INVESTMENT, 2011-2021
  • 5.7 TECHNOLOGY ANALYSIS
  • 5.8 CASE STUDY ANALYSIS
  • 5.9 PRICING ANALYSIS
    • FIGURE 27 AVERAGE PRICE COMPETITIVENESS IN BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2022
    • FIGURE 28 AVERAGE PRICE COMPETITIVENESS IN BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2022
    • FIGURE 29 AVERAGE PRICE COMPETITIVENESS IN BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2022
  • 5.10 TRADE DATA STATISTICS
    • TABLE 6 COUNTRY-WISE EXPORT DATA, 2020-2022 (TON)
    • TABLE 7 COUNTRY-WISE IMPORT DATA, 2020-2022 (TON)
    • TABLE 8 COUNTRY-WISE EXPORT DATA, 2020-2022 (USD THOUSAND)
    • TABLE 9 COUNTRY-WISE IMPORT DATA, 2020-2022 (USD THOUSAND)
  • 5.11 GLOBAL ECONOMIC SCENARIO AFFECTING MARKET GROWTH
    • 5.11.1 IMPACT OF SLOWDOWN/RECESSION
      • 5.11.1.1 Russia-Ukraine war
      • 5.11.1.2 Recession in Europe
      • 5.11.1.3 Energy crisis in Europe
      • 5.11.1.4 Recession impact on Asia Pacific
  • 5.12 VALUE CHAIN ANALYSIS
  • 5.13 ECOSYSTEM ANALYSIS AND INTERCONNECTED MARKETS
    • TABLE 10 BIOCOMPATIBLE COATINGS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
    • FIGURE 30 PAINTS & COATINGS MARKET: ECOSYSTEM ANALYSIS
  • 5.14 TRENDS/DISRUPTIONS IMPACTING BUYERS/CUSTOMERS
    • FIGURE 31 REVENUE SHIFT IN BIOCOMPATIBLE COATINGS MARKET
  • 5.15 PATENT ANALYSIS
    • 5.15.1 METHODOLOGY
    • 5.15.2 PUBLICATION TRENDS
    • FIGURE 32 NUMBER OF PATENTS PUBLISHED, 2018-2023
    • 5.15.3 TOP APPLICANTS
    • FIGURE 33 PATENTS PUBLISHED BY MAJOR PLAYERS, 2018-2022
    • 5.15.4 JURISDICTION
    • FIGURE 34 PATENTS PUBLISHED, BY JURISDICTION, 2018-2022
    • TABLE 11 RECENT PATENTS BY COMPANIES
  • 5.16 TARIFF AND REGULATORY LANDSCAPE
    • 5.16.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 14 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.17 REGULATORY LANDSCAPE AND STANDARDS
    • 5.17.1 LEGISLATIVE AND REGULATORY POLICY UPDATE
      • 5.17.1.1 Industrial surface coating regulation update
      • 5.17.1.2 VOC regulations
      • 5.17.1.3 HAP regulations
    • TABLE 16 INTERNATIONALLY RECOGNIZED TEST METHODS FOR BIOCOMPATIBLE COATINGS
  • 5.18 KEY CONFERENCES AND EVENTS IN 2023
    • TABLE 17 BIOCOMPATIBLE COATINGS MARKET: KEY CONFERENCES AND EVENTS

6 BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE

  • 6.1 INTRODUCTION
    • FIGURE 35 POLYMER BIOCOMPATIBLE COATINGS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
    • TABLE 18 BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2021-2022 (KILOTON)
    • TABLE 19 BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2023-2028 (KILOTON)
    • TABLE 20 BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2021-2022 (USD MILLION)
    • TABLE 21 BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2023-2028 (USD MILLION)
  • 6.2 POLYMER
    • 6.2.1 MINIMIZES ADVERSE REACTIONS AND PROMOTES FAVORABLE INTERACTIONS WITH BIOLOGICAL SYSTEMS
    • TABLE 22 POLYMER BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2021-2022 (KILOTON)
    • TABLE 23 POLYMER BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2023-2028 (KILOTON)
    • TABLE 24 POLYMER BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2021-2022 (USD MILLION)
    • TABLE 25 POLYMER BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 6.3 CERAMIC
    • 6.3.1 SHOWS EXCELLENT MECHANICAL STRENGTH IN HIGH-PERFORMANCE APPLICATIONS
    • TABLE 26 CERAMIC BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2021-2022 (KILOTON)
    • TABLE 27 CERAMIC BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2023-2028 (KILOTON)
    • TABLE 28 CERAMIC BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2021-2022 (USD MILLION)
    • TABLE 29 CERAMIC BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 6.4 METAL
    • 6.4.1 EXHIBITS SUPERIOR WEAR RESISTANCE AND IMPROVED LONG-TERM PERFORMANCE
    • TABLE 30 METAL BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2021-2022 (KILOTON)
    • TABLE 31 METAL BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2023-2028 (KILOTON)
    • TABLE 32 METAL BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2021-2022 (USD MILLION)
    • TABLE 33 METAL BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 6.5 OTHERS
    • TABLE 34 OTHER BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2021-2022 (KILOTON)
    • TABLE 35 OTHER BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2023-2028 (KILOTON)
    • TABLE 36 OTHER BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2021-2022 (USD MILLION)
    • TABLE 37 OTHER BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2023-2028 (USD MILLION)

7 BIOCOMPATIBLE COATINGS MARKET, BY COATING TYPE

  • 7.1 INTRODUCTION
  • 7.2 ANTIBACTERIAL COATINGS
  • 7.3 HYDROPHILIC COATINGS
  • 7.4 OTHERS

8 BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY

  • 8.1 INTRODUCTION
    • FIGURE 36 MEDICAL DEVICE TO BE FASTEST-GROWING END-USE INDUSTRY DURING FORECAST PERIOD
    • TABLE 38 BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2021-2022 (KILOTON)
    • TABLE 39 BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2023-2028 (KILOTON)
    • TABLE 40 BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2021-2022 (USD MILLION)
    • TABLE 41 BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2023-2028 (USD MILLION)
  • 8.2 HEALTHCARE
    • 8.2.1 RISE IN CHRONIC DISEASES AND AGING POPULATION TO DRIVE MARKET
    • TABLE 42 BIOCOMPATIBLE COATINGS MARKET IN HEALTHCARE END USE INDUSTRY, BY REGION, 2021-2022 (KILOTON)
    • TABLE 43 BIOCOMPATIBLE COATINGS MARKET IN HEALTHCARE END USE INDUSTRY, BY REGION, 2023-2028 (KILOTON)
    • TABLE 44 BIOCOMPATIBLE COATINGS MARKET IN HEALTHCARE END USE INDUSTRY, BY REGION, 2021-2022 (USD MILLION)
    • TABLE 45 BIOCOMPATIBLE COATINGS MARKET IN IN HEALTHCARE END USE INDUSTRY, BY REGION, 2023-2028 (USD MILLION)
  • 8.3 FOOD & BEVERAGE
    • 8.3.1 INCREASING FOCUS ON FOOD SAFETY AND SHELF LIFE EXTENSION TO DRIVE MARKET
    • TABLE 46 BIOCOMPATIBLE COATINGS MARKET IN FOOD & BEVERAGE END USE INDUSTRY, BY REGION, 2021-2022 (KILOTON)
    • TABLE 47 BIOCOMPATIBLE COATINGS MARKET IN FOOD & BEVERAGE END USE INDUSTRY, BY REGION, 2023-2028 (KILOTON)
    • TABLE 48 BIOCOMPATIBLE COATINGS MARKET IN FOOD & BEVERAGE END USE INDUSTRY, BY REGION, 2021-2022 (USD MILLION)
    • TABLE 49 BIOCOMPATIBLE COATINGS MARKET IN FOOD & BEVERAGE END USE INDUSTRY, BY REGION, 2023-2028 (USD MILLION)
  • 8.4 MEDICAL DEVICE
    • 8.4.1 FOCUS ON INFECTION CONTROL TO DRIVE MARKET
    • TABLE 50 BIOCOMPATIBLE COATINGS MARKET IN MEDICAL DEVICE END USE INDUSTRY, BY REGION, 2021-2022 (KILOTON)
    • TABLE 51 BIOCOMPATIBLE COATINGS MARKET IN MEDICAL DEVICE END USE INDUSTRY, BY REGION, 2023-2028 (KILOTON)
    • TABLE 52 BIOCOMPATIBLE COATINGS MARKET IN MEDICAL DEVICE END USE INDUSTRY, BY REGION, 2021-2022 (USD MILLION)
    • TABLE 53 BIOCOMPATIBLE COATINGS MARKET IN MEDICAL DEVICE END USE INDUSTRY, BY REGION, 2023-2028 (USD MILLION)
  • 8.5 OTHERS
    • TABLE 54 BIOCOMPATIBLE COATINGS MARKET IN OTHER END USE INDUSTRIES, BY REGION, 2021-2022 (KILOTON)
    • TABLE 55 BIOCOMPATIBLE COATINGS MARKET IN OTHER END USE INDUSTRIES, BY REGION, 2023-2028 (KILOTON)
    • TABLE 56 BIOCOMPATIBLE COATINGS MARKET IN OTHER END USE INDUSTRIES, BY REGION, 2021-2022 (USD MILLION)
    • TABLE 57 BIOCOMPATIBLE COATINGS MARKET IN OTHER END USE INDUSTRIES, BY REGION, 2023-2028 (USD MILLION)

9 BIOCOMPATIBLE COATINGS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • 9.1.1 RECESSION IMPACT ANALYSIS
    • FIGURE 37 NORTH AMERICA TO DOMINATE BIOCOMPATIBLE COATINGS MARKET DURING FORECAST PERIOD
    • TABLE 58 BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2021-2022 (KILOTON)
    • TABLE 59 BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2023-2028 (KILOTON)
    • TABLE 60 BIOCOMPATIBLE COATINGS MARKET, BY REGION, 2021-2022 (USD MILLION)
    • TABLE 61 BIOCOMPATIBLE COATINGS MARKET BY REGION, 2023-2028 (USD MILLION)
  • 9.2 ASIA PACIFIC
    • 9.2.1 IMPACT OF RECESSION ON ASIA PACIFIC
    • FIGURE 38 ASIA PACIFIC: BIOCOMPATIBLE COATINGS MARKET SNAPSHOT
    • TABLE 62 ASIA PACIFIC: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2021-2022 (KILOTON)
    • TABLE 63 ASIA PACIFIC: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2023-2028 (KILOTON)
    • TABLE 64 ASIA PACIFIC: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2021-2022 (USD MILLION)
    • TABLE 65 ASIA PACIFIC: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 66 ASIA PACIFIC: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2021-2022 (KILOTON)
    • TABLE 67 ASIA PACIFIC: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2023-2028 (KILOTON)
    • TABLE 68 ASIA PACIFIC: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2021-2022 (USD MILLION)
    • TABLE 69 ASIA PACIFIC: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2023-2028 (USD MILLION)
    • TABLE 70 ASIA PACIFIC: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2021-2022 (KILOTON)
    • TABLE 71 ASIA PACIFIC: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2023-2028 (KILOTON)
    • TABLE 72 ASIA PACIFIC: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2021-2022 (USD MILLION)
    • TABLE 73 ASIA PACIFIC: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2023-2028 (USD MILLION)
    • 9.2.2 CHINA
      • 9.2.2.1 Increased spending on healthcare to drive market
    • 9.2.3 JAPAN
      • 9.2.3.1 Focus on technological advancements in healthcare industry to drive market
    • 9.2.4 INDIA
      • 9.2.4.1 Growing healthcare industry to drive market
    • 9.2.5 SOUTH KOREA
      • 9.2.5.1 Increasing healthcare expenditure to drive market
    • 9.2.6 REST OF ASIA PACIFIC
  • 9.3 NORTH AMERICA
    • 9.3.1 IMPACT OF RECESSION ON NORTH AMERICA
    • FIGURE 39 NORTH AMERICA: BIOCOMPATIBLE COATINGS MARKET SNAPSHOT
    • TABLE 74 NORTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2021-2022 (KILOTON)
    • TABLE 75 NORTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2023-2028 (KILOTON)
    • TABLE 76 NORTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2021-2022 (USD MILLION)
    • TABLE 77 NORTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 78 NORTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2021-2022 (KILOTON)
    • TABLE 79 NORTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2023-2028 (KILOTON)
    • TABLE 80 NORTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2021-2022 (USD MILLION)
    • TABLE 81 NORTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2023-2028 (USD MILLION)
    • TABLE 82 NORTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2021-2022 (KILOTON)
    • TABLE 83 NORTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2023-2028 (KILOTON)
    • TABLE 84 NORTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2021-2022 (USD MILLION)
    • TABLE 85 NORTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2023-2028 (USD MILLION)
    • 9.3.2 US
      • 9.3.2.1 Advancements in medical technology and food & beverage industry to drive market
    • 9.3.3 CANADA
      • 9.3.3.1 Demand from medical devices and consumer goods to drive market
    • 9.3.4 MEXICO
      • 9.3.4.1 Demand from consumer goods industry to drive market
  • 9.4 EUROPE
    • 9.4.1 IMPACT OF RECESSION ON EUROPE
    • FIGURE 40 EUROPE: BIOCOMPATIBLE COATINGS MARKET SNAPSHOT
    • TABLE 86 EUROPE: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2021-2022 (KILOTON)
    • TABLE 87 EUROPE: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2023-2028 (KILOTON)
    • TABLE 88 EUROPE: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2021-2022 (USD MILLION)
    • TABLE 89 EUROPE: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 90 EUROPE: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2021-2022 (KILOTON)
    • TABLE 91 EUROPE: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2023-2028 (KILOTON)
    • TABLE 92 EUROPE: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2021-2022 (USD MILLION)
    • TABLE 93 EUROPE: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2023-2028 (USD MILLION)
    • TABLE 94 EUROPE: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2021-2022 (KILOTON)
    • TABLE 95 EUROPE: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2023-2028 (KILOTON)
    • TABLE 96 EUROPE: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2021-2022 (USD MILLION)
    • TABLE 97 EUROPE: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2023-2028 (USD MILLION)
    • 9.4.2 GERMANY
      • 9.4.2.1 Growing healthcare and consumer goods industries to drive market
    • 9.4.3 FRANCE
      • 9.4.3.1 Growing healthcare expenditure to drive market
    • 9.4.4 UK
      • 9.4.4.1 Strict regulatory compliance requirements to drive market
    • 9.4.5 ITALY
      • 9.4.5.1 Booming healthcare industry to drive demand
    • 9.4.6 REST OF EUROPE
  • 9.5 MIDDLE EAST & AFRICA
    • 9.5.1 IMPACT OF RECESSION ON MIDDLE EAST & AFRICA
    • FIGURE 41 MIDDLE EAST & AFRICA: BIOCOMPATIBLE COATINGS MARKET SNAPSHOT
    • TABLE 98 MIDDLE EAST & AFRICA: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2021-2022 (KILOTON)
    • TABLE 99 MIDDLE EAST & AFRICA: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2023-2028 (KILOTON)
    • TABLE 100 MIDDLE EAST & AFRICA: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2021-2022 (USD MILLION)
    • TABLE 101 MIDDLE EAST & AFRICA: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 102 MIDDLE EAST & AFRICA: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2021-2022 (KILOTON)
    • TABLE 103 MIDDLE EAST & AFRICA: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2023-2028 (KILOTON)
    • TABLE 104 MIDDLE EAST & AFRICA: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2021-2022 (USD MILLION)
    • TABLE 105 MIDDLE EAST & AFRICA: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2023-2028 (USD MILLION)
    • TABLE 106 MIDDLE EAST & AFRICA: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2021-2022 (KILOTON)
    • TABLE 107 MIDDLE EAST & AFRICA: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2023-2028 (KILOTON)
    • TABLE 108 MIDDLE EAST & AFRICA: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2021-2022 (USD MILLION)
    • TABLE 109 MIDDLE EAST & AFRICA: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2023-2028 (USD MILLION)
    • 9.5.2 SAUDI ARABIA
      • 9.5.2.1 Government investments in healthcare industry to drive market
    • 9.5.3 UAE
      • 9.5.3.1 Medical tourism to drive market
    • 9.5.4 REST OF MIDDLE EAST & AFRICA
  • 9.6 SOUTH AMERICA
    • 9.6.1 IMPACT OF RECESSION ON SOUTH AMERICA
    • FIGURE 42 SOUTH AMERICA: BIOCOMPATIBLE COATINGS MARKET SNAPSHOT
    • TABLE 110 SOUTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2021-2022 (KILOTON)
    • TABLE 111 SOUTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2023-2028 (KILOTON)
    • TABLE 112 SOUTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2021-2022 (USD MILLION)
    • TABLE 113 SOUTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 114 SOUTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2021-2022 (KILOTON)
    • TABLE 115 SOUTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2023-2028 (KILOTON)
    • TABLE 116 SOUTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2021-2022 (USD MILLION)
    • TABLE 117 SOUTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY MATERIAL TYPE, 2023-2028 (USD MILLION)
    • TABLE 118 SOUTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2021-2022 (KILOTON)
    • TABLE 119 SOUTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2023-2028 (KILOTON)
    • TABLE 120 SOUTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2021-2022 (USD MILLION)
    • TABLE 121 SOUTH AMERICA: BIOCOMPATIBLE COATINGS MARKET, BY END USE INDUSTRY, 2023-2028 (USD MILLION)
    • 9.6.2 BRAZIL
      • 9.6.2.1 Demand for medical devices to drive market
    • 9.6.3 ARGENTINA
      • 9.6.3.1 Focus on sustainability and environmental conservation to drive market
    • 9.6.4 REST OF SOUTH AMERICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • TABLE 122 STRATEGIES ADOPTED BY KEY BIOCOMPATIBLE COATINGS MARKET PLAYERS (2018-2022)
  • 10.2 COMPANY EVALUATION MATRIX, 2022
    • 10.2.1 STARS
    • 10.2.2 PERVASIVE PLAYERS
    • 10.2.3 EMERGING LEADERS
    • 10.2.4 PARTICIPANTS
    • FIGURE 43 BIOCOMPATIBLE COATINGS MARKET: COMPANY EVALUATION MATRIX, 2022
  • 10.3 STARTUP/SME EVALUATION MATRIX, 2022
    • 10.3.1 PROGRESSIVE COMPANIES
    • 10.3.2 STARTING BLOCKS
    • 10.3.3 RESPONSIVE COMPANIES
    • 10.3.4 DYNAMIC COMPANIES
    • FIGURE 44 BIOCOMPATIBLE COATINGS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022
  • 10.4 COMPETITIVE BENCHMARKING
    • TABLE 123 BIOCOMPATIBLE COATINGS MARKET: KEY STARTUPS/SMES
    • TABLE 124 BIOCOMPATIBLE COATINGS MARKET: KEY COMPANY FOOTPRINT
    • TABLE 125 BIOCOMPATIBLE COATINGS MARKET: STARTUP/SME FOOTPRINT
  • 10.5 MARKET SHARE ANALYSIS
    • FIGURE 45 BIOCOMPATIBLE COATINGS MARKET SHARE ANALYSIS FOR KEY PLAYERS (2022)
    • TABLE 126 BIOCOMPATIBLE COATINGS MARKET: DEGREE OF COMPETITION, 2022
  • 10.6 MARKET RANKING ANALYSIS
    • FIGURE 46 RANKING OF LEADING PLAYERS IN BIOCOMPATIBLE COATINGS MARKET, 2022
  • 10.7 REVENUE ANALYSIS
    • FIGURE 47 REVENUE ANALYSIS OF TOP 5 PLAYERS, 2018-2022
  • 10.8 COMPETITIVE SCENARIO
    • 10.8.1 MARKET EVALUATION FRAMEWORK
    • TABLE 127 STRATEGIC DEVELOPMENTS, BY COMPANY
    • TABLE 128 HIGHEST ADOPTED STRATEGIES
    • TABLE 129 NUMBER OF GROWTH STRATEGIES ADOPTED BY KEY COMPANIES
    • 10.8.2 MARKET EVALUATION MATRIX
    • TABLE 130 COMPANY END USE INDUSTRY FOOTPRINT
    • TABLE 131 COMPANY REGION FOOTPRINT
    • TABLE 132 COMPANY OVERALL FOOTPRINT
  • 10.9 STRATEGIC DEVELOPMENTS
    • TABLE 133 BIOCOMPATIBLE COATINGS MARKET: DEALS, 2018-2023

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)**
    • 11.1.1 SURMODICS, INC.
    • TABLE 134 SURMODICS, INC.: COMPANY OVERVIEW
    • FIGURE 48 SURMODICS, INC.: COMPANY SNAPSHOT
    • TABLE 135 SURMODICS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 136 SURMODICS, INC.: DEALS
    • 11.1.2 DSM BIOMEDICAL
    • TABLE 137 DSM BIOMEDICAL: COMPANY OVERVIEW
    • FIGURE 49 DSM BIOMEDICAL: COMPANY SNAPSHOT
    • TABLE 138 DSM BIOMEDICAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 139 DSM BIOMEDICAL: DEALS
    • 11.1.3 HYDROMER, INC.
    • TABLE 140 HYDROMER, INC.: COMPANY OVERVIEW
    • FIGURE 50 HYDROMER, INC.: COMPANY SNAPSHOT
    • TABLE 141 HYDROMER, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 142 HYDROMER, INC.: DEALS
    • 11.1.4 AST PRODUCTS, INC.
    • TABLE 143 AST PRODUCTS, INC.: COMPANY OVERVIEW
    • TABLE 144 AST PRODUCTS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.1.5 BIOCOAT INCORPORATED
    • TABLE 145 BIOCOAT INCORPORATED: COMPANY OVERVIEW
    • TABLE 146 BIOCOAT INCORPORATED: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.1.6 BIOINTERACTIONS LIMITED
    • TABLE 147 BIOINTERACTIONS LIMITED: COMPANY OVERVIEW
    • TABLE 148 BIOINTERACTIONS LIMITED: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.1.7 FREUDENBERG MEDICAL
    • TABLE 149 FREUDENBERG MEDICAL: COMPANY OVERVIEW
    • TABLE 150 FREUDENBERG MEDICAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.1.8 COVALON TECHNOLOGIES LTD.
    • TABLE 151 COVALON TECHNOLOGIES LTD.: COMPANY OVERVIEW
    • TABLE 152 COVALON TECHNOLOGIES LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.1.9 ACULON, INC
    • TABLE 153 ACULON, INC: COMPANY OVERVIEW
    • TABLE 154 ACULON, INC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.1.10 APPLIED MEDICAL COATINGS
    • TABLE 155 APPLIED MEDICAL COATINGS: COMPANY OVERVIEW
    • TABLE 156 APPLIED MEDICAL COATINGS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • 11.2 OTHER KEY PLAYERS
    • 11.2.1 ADVANSOURCE BIOMATERIALS CORPORATION
    • TABLE 157 ADVANSOURCE BIOMATERIALS CORPORATION: COMPANY OVERVIEW
    • TABLE 158 ADVANSOURCE BIOMATERIALS CORPORATION: PRODUCTS/SERVICES/ SOLUTIONS OFFERED
    • 11.2.2 SURFACE SOLUTIONS GROUP, LLC
    • TABLE 159 SURFACE SOLUTIONS GROUP, LLC: COMPANY OVERVIEW
    • TABLE 160 SURFACE SOLUTIONS GROUP, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.2.3 LINCOTEK MEDICAL
    • TABLE 161 LINCOTEK MEDICAL: COMPANY OVERVIEW
    • TABLE 162 LINCOTEK MEDICAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.2.4 POLY-MED, INC.
    • TABLE 163 POLY-MED, INC.: COMPANY OVERVIEW
    • TABLE 164 POLY-MED, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.2.5 PRECISION COATING COMPANY, INC.
    • TABLE 165 PRECISION COATING COMPANY, INC.: COMPANY OVERVIEW
    • TABLE 166 PRECISION COATING COMPANY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.2.6 SPECIALTY COATING SYSTEMS, INC.
    • TABLE 167 SPECIALTY COATING SYSTEMS, INC.: COMPANY OVERVIEW
    • TABLE 168 SPECIALTY COATING SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.2.7 HEMOTEQ AG
    • TABLE 169 HEMOTEQ AG: COMPANY OVERVIEW
    • TABLE 170 HEMOTEQ AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.2.8 HARLAND MEDICAL SYSTEMS
    • TABLE 171 HARLAND MEDICAL SYSTEMS: COMPANY OVERVIEW
    • TABLE 172 HARLAND MEDICAL SYSTEMS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.2.9 ISURTEC
    • TABLE 173 ISURTEC: COMPANY OVERVIEW
    • TABLE 174 ISURTEC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.2.10 WHITFORD CORPORATION
    • TABLE 175 WHITFORD CORPORATION: COMPANY OVERVIEW
    • TABLE 176 WHITFORD CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.2.11 MILLER-STEPHENSON
    • TABLE 177 MILLER-STEPHENSON: COMPANY OVERVIEW
    • TABLE 178 MILLER-STEPHENSON: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.2.12 ENDURA COATINGS
    • TABLE 179 ENDURA COATINGS: COMPANY OVERVIEW
    • TABLE 180 ENDURA COATINGS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.2.13 APPLIED MEMBRANE TECHNOLOGY
    • TABLE 181 APPLIED MEMBRANE TECHNOLOGY: COMPANY OVERVIEW
    • TABLE 182 APPLIED MEMBRANE TECHNOLOGY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.2.14 COATINGS2GO
    • TABLE 183 COATINGS2GO: COMPANY OVERVIEW
    • TABLE 184 COATINGS2GO: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 11.2.15 FORMACOAT, LLC
    • TABLE 185 FORMACOAT, LLC: COMPANY OVERVIEW
    • TABLE 186 FORMACOAT, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • *Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)** might not be captured in case of unlisted companies.

12 ADJACENT AND RELATED MARKETS

  • 12.1 INTRODUCTION
    • 12.1.1 HYDROPHILIC COATINGS MARKET LIMITATIONS
  • 12.2 HYDROPHILIC COATINGS MARKET DEFINITION
  • 12.3 HYDROPHILIC COATINGS MARKET OVERVIEW
    • 12.3.1 HYDROPHILIC COATINGS MARKET ANALYSIS, BY SUBSTRATE
    • TABLE 187 HYDROPHILIC COATINGS MARKET, BY SUBSTRATE, 2018-2021 (USD MILLION)
    • TABLE 188 HYDROPHILIC COATINGS MARKET, BY SUBSTRATE, 2022-2027 (USD MILLION)
    • TABLE 189 HYDROPHILIC COATINGS MARKET, BY SUBSTRATE, 2018-2021 (KILOTON)
    • TABLE 190 HYDROPHILIC COATINGS MARKET, BY SUBSTRATE, 2022-2027 (KILOTON)
    • 12.3.2 HYDROPHILIC COATINGS MARKET ANALYSIS, BY END USER
    • TABLE 191 HYDROPHILIC COATINGS MARKET, BY END USER, 2018-2021 (USD MILLION)
    • TABLE 192 HYDROPHILIC COATINGS MARKET, BY END USER, 2022-2027 (USD MILLION)
    • TABLE 193 HYDROPHILIC COATINGS MARKET, BY END USER, 2018-2021 (KILOTON)
    • TABLE 194 HYDROPHILIC COATINGS MARKET, BY END USER, 2022-2027 (KILOTON)
    • 12.3.3 HYDROPHILIC COATINGS MARKET ANALYSIS, BY REGION
    • TABLE 195 HYDROPHILIC COATINGS MARKET, BY REGION, 2018-2021 (USD MILLION)
    • TABLE 196 HYDROPHILIC COATINGS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 197 HYDROPHILIC COATINGS MARKET, BY REGION, 2018-2021 (KILOTON)
    • TABLE 198 HYDROPHILIC COATINGS MARKET, BY REGION, 2022-2027 (KILOTON)

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS